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Background: Hypercholesterolemia can elicit progressive inflammation and atherosclerotic lesions, particularly at arterial wall sites with low fluid 
shear stress or turbulent blood flow, while adjacent regions exposed to laminar flow and high mean shear stress are protected from atherogenesis. 
EECP effectively increases blood flow and arterial wall shear stress in vivo. This study investigates the effect of EECP on atherosclerosis progression 
and the underlying inflammation- related molecular mechanisms in a pig model of hypercholesterolemia.
Methods: Twenty eight domestic male pigs made hypercholesterolemic and maintained on an atherogenic diet were randomized to EECP treatment 
(17) or control group (11). EECP was performed 2- hours every other day for a total of 34±2 hours over 7 weeks using a commercial available 
system. Immunohistochemistry, immunofluorescence, and atherosclerosis quantification were performed.
Results: The EECP treated pigs showed a marked reduction in atherosclerotic lesion size: coronary (lesion/ media area ratio: 7.32±1.59 
% versus 26.57±4.56 %, p < 0.001), abdominal aorta (% of plaque area: 3.33±0.60 % versus 12.03±2.15%, p< 0.001), compared to the 
hypercholesterolemic controls, together with a decrease in coronary artery macrophage accumulation (5.58 ±0.49 versus 9.30 ±0.71 %, p < 
0.001) and C3a deposition (12.98 ±0.66 versus 18.56±0.90 %, p = 0.001). The inflammation- relevant molecules including CRP, VCAM-1 and iNOs 
expression were down- regulated. Furthermore, MAPK-p38 phosphorylation, NF-κB activation was significantly attenuated by immunohistochemistry 
and molecular biological techniques.
Conclusions: The present study suggests that long- term EECP can exert a retarding effect on atherosclerosis progression by reducing vascular 
inflammation and downregulating proinflammatory gene expression. The underlying mechanisms are related to EECP suppressing the over- 
activation of the MAPK-P38/ NF-κB/ VCAM-1 signaling pathway induced by hypercholesterolemia. Long- term EECP intervention may be an effective 
complementary therapeutic strategy to protect the cardiovascular system from inflammation and atherosclerosis.
